Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 25,100 US PATENTS IN FORCE
- 46,411 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 217,140 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| RE49918 | Cytotoxic benzodiazepine derivatives | May 10, 21 | Apr 16, 24 | Immunogen Inc. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0122,184 | SYSTEMS AND METHODS FOR IDENTIFYING GAS CONCENTRATIONS USING AN MOX SENSOR | Dec 24, 23 | Apr 18, 24 | Chorus, LLC |
| 2024/0122,210 | MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION | Dec 22, 23 | Apr 18, 24 | Native Microbials, Inc. |
| 2024/0123,022 | A STABLE ANTI-ANGIOGENIC AND ANTI-INFLAMMATORY PHARMACEUTICAL FORMULATION AND PHARMACEUTICAL COMBINATION FOR TREATMENT AND PREVENTION OF PSORIASIS | Jun 09, 22 | Apr 18, 24 | Not available |
| 2024/0123,026 | Actinohivin Variant Polypeptides and Related Methods | Mar 04, 22 | Apr 18, 24 | Not available |
| 2024/0123,032 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORNEAL HAZE AND SCARRING | Jun 01, 23 | Apr 18, 24 | Not available |
| 2024/0123,034 | MRNAS ENCODING GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR FOR TREATING PARKINSON'S DISEASE | Oct 15, 20 | Apr 18, 24 | Not available |
| 2024/0123,036 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE | Jan 28, 22 | Apr 18, 24 | Not available |
| 2024/0123,040 | COMPOSITIONS, DEVICES AND METHODS FOR TREATING MPS VI DISEASE | Feb 04, 22 | Apr 18, 24 | Not available |
| 2024/0123,048 | ATTENUATED AFRICAN SWINE FEVER VIRUS AND ITS USE AS A VACCINE | Jan 31, 22 | Apr 18, 24 | Not available |
| 2024/0123,050 | Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus | May 01, 23 | Apr 18, 24 | Not available |
| 2024/0123,052 | Vaccines For Recurrent Respiratory Papillomatosis And Methods of Using the Same | Oct 13, 23 | Apr 18, 24 | Not available |
| 2024/0123,058 | EPITOPE PEPTIDE AND ANTIBODY FOR PREVENTING AND TREATING EB VIRUS INFECTION AND RELATED DISEASES | Jan 29, 22 | Apr 18, 24 | Not available |
| 2024/0123,060 | IMPROVED THERAPEUTIC COMPOSITION COMPRISING HEPATITIS B ANTIGEN HAVING S, PRE-S1 AND PRE-S2 PROTEIN, ALUMINIUM PHOSPHATE AND INTERFERON-ALPHA AND USE THEREOF FOR TREATMENT OF HEPATITIS B | Jun 19, 20 | Apr 18, 24 | Not available |
| 2024/0123,062 | BIVALENT DENGUE/HEPATITUS B VACCINES | Sep 21, 23 | Apr 18, 24 | Not available |
| 2024/0123,068 | CD19 BINDERS, CAR-T CONSTRUCTS COMPRISING THE SAME, AND METHODS OF USING THE SAME | Oct 18, 23 | Apr 18, 24 | Kite Pharma, Inc.; The Trustees of the University of Pennsylvania; |
| 2024/0123,070 | EPITOPE PEPTIDE OF RAS G13D MUTANT AND T CELL RECEPTOR RECOGNIZING RAS G13D MUTANT | Jan 29, 22 | Apr 18, 24 | Not available |
| 2024/0123,080 | CYTOTOXIC COMPOUNDS AND CONJUGATES THEREOF | Aug 11, 23 | Apr 18, 24 | Not available |
| 2024/0123,090 | COMPOSITIONS AND METHODS FOR ENHANCING GAMMA DELTA T CELLS IN THE GUT | Aug 11, 23 | Apr 18, 24 | King's College London |
| 2024/0123,092 | PHOTOSENSITIZER-PEPTIDE CONJUGATE WITH CLEAVABLE LINKER, AND COMPOSITION FOR PHOTODYNAMIC DIAGNOSIS OR TREATMENT COMPRISING SAME | Sep 15, 23 | Apr 18, 24 | National Cancer Center |
| 2024/0123,098 | STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF | Nov 16, 23 | Apr 18, 24 | Not available |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)